Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
53,541,175
-
Share change
-
-351,904
-
Total reported value
-
$1,346,020,457
-
Put/Call ratio
-
63%
-
Price per share
-
$25.14
-
Number of holders
-
166
-
Value change
-
-$8,790,587
-
Number of buys
-
3
-
Number of sells
-
4
Institutional Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q4 2013
As of 31 Dec 2013,
IMPAX LABORATORIES INC - COM (IPXL) was held by
166 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
53,541,175 shares.
The largest 10 holders included
BlackRock Fund Advisors, FMR LLC, ORBIMED ADVISORS LLC, VANGUARD GROUP INC, RS INVESTMENT MANAGEMENT CO LLC, UBS GLOBAL ASSET MANAGEMENT AMERICAS INC, BlackRock Institutional Trust Company, N.A., State Street Corp, Ameriprise Financial Inc, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
166
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.